Previous reports have pointed out that dopamine D2 receptor agonists such as bromocriptine can have a therapeutic effect in type 2 diabetes mellitus by improving glycemic control and glucose tolerance26. The gene discussed is DRD2; the disease is type 2 diabetes mellitus.